Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Numinus Wellness Inc (NUMI)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.085 +0.015    +21.43%
17/04 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 1,223,551
  • Bid/Ask: 0.085 / 0.090
  • Day's Range: 0.070 - 0.085
Numinus Wellness Inc 0.085 +0.015 +21.43%

Numinus Wellness Inc Company Profile

 
Get an in-depth profile of Numinus Wellness Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

Contact Information

Address 666 Burrard Street Suite 2500 Park Place
Vancouver, V6C 2X8
Canada
Phone 833 686 4687
Fax -
Web www.numinus.com

Top Executives

Name Age Since Title
Allen Morishita 75 2012 Independent Director
Payton Nyquvest - 2020 Founder, CEO & Chairman
Michael Tan - 2020 President, COO & Director
Larry Elwood Timlick 66 2019 Independent Director
Pamela Hadfield - 2020 Member of General Advisory Counsel
Gabor Mate - 2020 Member of the Clinical Advisory Council
Graham Pechenik - 2022 Member of Bioscience Advisory Board
Nichol Bradford - 2020 Member of General Advisory Counsel
Kate Browning - 2020 Member of the Clinical Advisory Council
Paul Spagnuolo - 2022 Member of Bioscience Advisory Board
Cory Harris - 2022 Member of Bioscience Advisory Board
Jamie Wheal - 2020 Member of General Advisory Counsel
Dennis McKenna - 2020 Member of General Advisory Counsel
Jason Marr - 2020 Member of the Clinical Advisory Council
Donna K. Wong 57 - Director
Pam Kryskow - 2020 Member of the Clinical Advisory Council
Zachary Walsh - 2020 Member of the Clinical Advisory Council
Ben Nemtin - 2020 Member of General Advisory Counsel
Donna Wilson - 2024 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NUMI Comments

Write your thoughts about Numinus Wellness Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gunnar Alpha
Gunnar Alpha Oct 16, 2022 11:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Been holding since the start. I think Numinus will be the future of this medical field. They have control of their whole line, production, research, running clinics. I predict huge numbers within 10 years. Psychadelics in health will be a thing of the future, anything else is impossible.
Reply
2 0
Report
Booger Tottenham III
Booger Tottenham III Jan 17, 2022 10:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think it could hit 4.20!
Reply
2 1
Report
Cassius Stone
Cassius Stone May 31, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why was this at $120 multiple times?
Reply
0 0
Report
Cassius Stone
Cassius Stone May 31, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Weed stock. Nevermind. I thought it was just for psychedelics.
Reply
0 0
Report
Gunnar Alpha
Gunnar Alpha May 31, 2021 9:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It's not a ****stock. This is the future of mental health. Government licenses for MDMA, Psilocybin, Ketsmine treatments. They got the whole supply line from lab to clinics.
Reply
1 0
Report
Smooth Operator
SmoothOperator Mar 30, 2021 11:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Very good entry point. Sector is still reeling, if you're looking for a decent entry you've found it at around the $1 mark.
Reply
2 0
Report
Smooth Operator
SmoothOperator Mar 16, 2021 10:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yea, let it work it out of it's system. It will take some time. Patience like all others in this sector.
Reply
3 0
Report
Trevor Taylor
Trevor Taylor Mar 15, 2021 12:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New bought deal good time to buy the dip
Reply
3 0
Report
kevin lin
kevin lin Mar 15, 2021 12:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how about the news today? any thoughts?
Reply
0 0
Report
kevin lin
kevin lin Mar 15, 2021 12:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how about the news today? any thoughts?
Reply
0 0
Report
Trevor Taylor
Trevor Taylor Mar 15, 2021 12:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think its positive giving numi more funding for r&d and the trials as well so hoping this rebounds fast to 1.40 plus
Reply
1 0
Report
kevin lin
kevin lin Mar 15, 2021 12:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it's drop to 1.14 omg still hold？
Reply
0 0
Report
Smooth Operator
SmoothOperator Feb 23, 2021 10:02AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Smokin buy today!
Reply
0 0
Report
Asad Asad
Asad Asad Feb 02, 2021 11:28AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It is hanging around ups one day and then wait for the down another day
Reply
0 0
Report
Lucas Sciacchitano
Lucas Sciacchitano Feb 01, 2021 2:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bullish hammer close friday, monday should be great
Reply
0 0
Report
Fernando Oniluap
Fernando Oniluap Jan 14, 2021 3:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Need to break that 1.33
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email